Alzheimer Studies Faulted for Waste, Ineffective Outcomes

Alzheimer Studies Faulted for Waste, Ineffective Outcomes
Sometimes more is not necessarily better. This may especially be true of Alzheimer's disease clinical studies, too many of which have been tried and failed, leading top scientists to question their design and execution. Better planning in the application of more promising approaches might make more sense — and improve a trial's chance of success. This concern was the topic of a recent symposium in Barcelona, Spain, where an international group of experts from academia and industry, as well as the editors from The Lancet journal, asked: Is there simply too much wasted effort in current Alzheimer's clinical trials? The symposium, part of the 8th International Conference on Clinical Trials for Alzheimer's Disease (CTAD),
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *